FDA Warns Against Compounded GLP-1 Drugs, Prompting Nationwide Recall
The FDA warned patients in October 2026 not to use unapproved compounded GLP-1 weight-loss drugs unless approved name-brand versions cannot meet their medical needs, and a nationwide recall of these compounded products followed.
2newsrooms
2articles
47 hoursrunning
Oct 21first seen
Ask Scout
Scout answers questions about this story using only the coverage below.
Coverage over time
Articles
| Oct 23, 11:36 AM | thehill.com | Nationwide recall on these compound GLP-1 drugs |
| Oct 21, 12:47 PM | bostonglobe.com | Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives |